Orbis Research has added “Celiac Disease (CD)- Market Insights, Epidemiology and Market Forecast-2023-United States” report to its Comprehensive Database.
The Report provides an overview of the Celiac Disease and current scenario of the disease in the United States. It also includes historical and forecasted epidemiological data for the diagnosed prevalent cases of Celiac Disease in the United States from 2013-2023.
Request a Sample of the Report at: http://www.orbisresearch.com/contacts/request-sample/209401
Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to damage in the small intestine. The number of ways celiac disease can affect patients, combined with a lack of training in medical schools and primary care residency programs, contributes to the poor diagnosis rate. Currently it is estimated that 80% of the celiac disease population remains undiagnosed. Prevalence in the United States ranges between 1 in 250. It is higher in relatives of people with celiac disease. Women are affected more commonly than men, but there is no age predilection.
DelveInsight forecasts predict that the total prevalent cases of Celiac Disease is expected to attenuate up to 0.2 Million by 2023 at a negative Compound Annual Growth Rate (CAGR) of 2.23% from 2013-2023 while the diagnosed prevalent population of Celiac Disease in the U.S. shall fall at a CAGR of 2.59% for the forecast period (2013-2023).
Get Complete Report Details at: http://www.orbisresearch.com/reports/index/celiac-disease-cd-epidemiology-insights-2023-united-states
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Scope of Report:
– Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
– It focuses on the detailed historical number of total prevalent cases as well as diagnosed prevalent cases of Celiac Disease in U.S. from 2013-2023.
– The report also includes forecastednumber of total prevalent cases as well as diagnosed prevalent cases of Celiac Disease in U.S. from 2016-2023.
Buy the Report at: http://www.orbisresearch.com/contact/purchase/209401
- Celiac Disease Overview
- Celiac Disease Types
- Non-Responsive or Refractory CD
- Disease Management
- Disease Treatment
- Treatment of Celiac Disease
- Treatment of Non-Responsive or Refractory Celiac Disease (RCD)
- Current Unmet Medical Needs
- Epidemiology Parameters
- Iceberg Model
- Genetic Predisposition
- Epidemiology &Patient Population
- Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023)
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/OrbisResearch